NCT06384300Not yet recruiting
Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China
Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China: An Individual Level Randomized Controlled Trial Study Protocol
Source: ClinicalTrials.gov · Last updated 25 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Gastric cancer, also known as stomach cancer, is a serious disease that affects the stomach. It's one of the most common types of cancer, and sadly, many people die from it each year. But there's hope! We can catch gastric cancer early with a special test called endoscopy. This test helps doctors find cancer or pre-cancerous changes in the stomach early, when it's easier to treat. However, not enough people get this test, especially in places where healthcare isn't easily available. That's why we're doing this study. We want to find out if we can encourage more people to get the endoscopy test for gastric cancer. We're going to try two different ways to encourage people to get the test. First, we'll give some people money or other incentives to help cover the costs of getting the test. Second, we'll give others information and support to help them understand why the test is important and how it can help them. We'll be doing this study in two provinces in China, where gastric cancer is a big problem. We'll ask thousands of people to join the study, and we'll randomly assign them to one of the two groups. Then, we'll see if more people in one group get the endoscopy test compared to the other group. Our hope is that by finding out what works best, we can help more people catch gastric cancer early and get the treatment they need. This could save many lives and make a big difference in fighting this disease.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 5000 (estimated)
- First submitted
- 22 Apr 2024
- Start date
- 1 Aug 2024
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Peking University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06384300
What you commit to
- Study type: Interventional
- Planned participants: 5000
- From 1 Aug 2024 to the primary completion date, 31 Jan 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of cancer or presence of precancerous lesions or conditions;
- Diagnosis of severe depression or psychiatric disorder;
- Presence of other medical conditions that preclude receipt of endoscopy services.
Lab values
- History of previous gastric cancer screening, including endoscopy and serum biomarker examination (pepsinogen, G-17, and MG7-Ag);
Other
- Having family members who have already participated in this study;
Who the study is looking for
- Provision of informed consent by patients;
- Identification as "high risk" (≥5 scores) by Gastric Cancer Risk Scoring System (GC-RSS).
Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.